BioSpace News Archive

CStone announces first patient dosed in China with BLU-667 for the global Phase I registrational study

CStone Pharmaceuticals announces the dosing of the first patient in China for the Phase I registrational study of BLU-667, which was discovered by the company’s partner Blueprint Medicines.

August 13, 2019

·

6 min read

Deals

AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio

Synpromics to operate as a wholly owned subsidiary; the two companies bring together pioneering technology to increase efficacy of gene therapeutics

August 13, 2019

·

6 min read

Drug Development

Terns Pharmaceuticals Announces Positive Interim Results From Ongoing Phase 1 Clinical Trial of TERN-201, a SSAO Inhibitor in Development for NASH

Terns Pharmaceuticals, Inc. announced the interim results of an ongoing Phase 1 clinical trial of TERN-201, a semicarbazide-sensitive amine oxidase inhibitor, being developed for the treatment of NASH.

August 13, 2019

·

4 min read

LEO Pharma A/S Acquires Rights to Develop and Market brodalumab for Moderate-to-Severe Psoriasis Outside of Europe

New sub-licensing agreement allows LEO Pharma to help more people around the world with an additional treatment option for psoriasis

August 13, 2019

·

4 min read

Deals

GraphPad Software Acquires SnapGene, Forms Insightful Science

Insightful Science is a technology company with category-leading software designed to empower scientists at every step of the research and development process

August 13, 2019

·

3 min read

BioCapital

New Research Identifies How Microbiome Can Increase Risk or Protection Against Sexually Transmitted Infections (STIs)

New research, published today in the flagship journal of the American Society for Microbiology, is the first to identify a specific mechanism by which keystone species of bacteria in the vaginal microbiome affect a woman’s susceptibility to sexually transmitted infections.

August 13, 2019

·

4 min read

Business

DarioHealth Reports Results For Second Quarter 2019

Global digital therapeutics innovator DarioHealth Corp., reported financial and operational results for the second quarter ended June 30, 2019.

August 13, 2019

·

11 min read

Business

Seven Bridges Expands Operations in Serbia to Facilitate Rapid Growth

Seven Bridges, the industry-leading bioinformatics solution provider, announced plans to expand operations into Novi Sad, Serbia in support of their growing customer base and to expedite product innovation.

August 13, 2019

·

2 min read

Drug Development

Lilly Announces Superiority of Taltz® (ixekizumab) versus TREMFYA® (guselkumab) in Delivering Total Skin Clearance at Week 12 in Topline Results from Head-to-Head (IXORA-R) Trial in People Living with Moderate to Severe Plaque Psoriasis

IXORA-R is the first Phase 4 head-to-head study comparing efficacy between an IL-17A inhibitor and an IL-23/p19 inhibitor using PASI 100 as the primary endpoint

August 13, 2019

·

8 min read

Pharm Country

Recovery Centers of America Opens Second Medication Assisted Treatment (“MAT”) Center in South Jersey to Meet Increased Treatment Need for Opioid Addicted Patients

The aftermath of the deluge of prescription pain pills that flooded New Jersey and other states in the last decade continues to cause an increased need for addiction treatment services for opioid dependency.

August 13, 2019

·

3 min read